South Korea Nasal Spray Market Forecast to 2026-2033

South Korea Nasal Spray Market

South Korea Nasal Spray Market By Product: (Decongestant Sprays, Steroid Sprays, Antihistamine Sprays, Saline Sprays, Combination Sprays, Anticholinergic Sprays, Other Nasal Sprays), By Indication: (Allergic Rhinitis, Non-Allergic Rhinitis, Nasal Congestion, Sinusitis, Common Cold, Nasal Polyps, Other Respiratory Conditions), By Dosage Form: (Aqueous Spray, Powder Spray, Gel Spray, Metered-Dose Spray, Pump Spray, Preservative-Free Spray, Combination Formulation), By Distribution: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drugstores, Supermarkets, Clinics, Direct Sales), By End User: (Adults, Pediatrics, Elderly, Allergy Patients, Cold & Flu Patients, Chronic Rhinitis Patients, Postoperative Patients) and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 2026-2033

Report ID : 9658 | Publisher ID : Transpire | Published : Nov 2026 | Pages : 189 | Format: PDF/EXCEL

Revenue, 2025 USD 1681.7 Million
Forecast, 2033 USD 2511.9 Million
CAGR, 2026-2033 5.04%
Report Coverage South Korea

South Korea Nasal Spray Market Summary:

According to Transpire Insight, a detailed research report on the market reflects that the allergic rhinitis and sinusitis application segment dominates the South Korea Nasal Spray Market, accounting for a significant share of the total market. Haleon PLC leads the market with its established nasal spray and consumer healthcare portfolio, making it a leading contributor to market development, product innovation, advanced intranasal drug-delivery solutions, expanding distribution capabilities, and growth dynamics.

Market Snapshot

  • Market Value (2025): USD 1681.7 Million.
  • Expected Market Value (2026): USD 1780.9 Million.
  • Estimated Market Value (2033): USD 2511.9 Million.
  • Forecast CAGR (2026–2033): 5.04%

Introduction

South Korean market for nasal sprays involves development, production, distribution, and sales of intranasal drug formulations or delivery devices to administer drugs for the treatment or prevention of medical conditions or nasal care through the nasal cavity. Some of the formulations administered using nasal sprays may be in the form of liquids, suspensions, or powders, and may be applied to treat rhinitis, nasal congestion, sinus conditions, and nasal care. The product lines under the market segment may include corticosteroids, antihistamines, decongestants, saline, and special types of nasal sprays. Growth drivers for the market may include convenience in drug administration, respiratory and allergy treatments, advanced metered dosage devices, and nasal care for pollutants.

South Korea Nasal Spray Market Size

Key Market Highlights: -

  • By Product, the Steroid dominated the market and holds approximately 41.2% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
  • By Indication, the Allergic Rhinitis dominated the market and holds approximately 55% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
  • By Dosage Form, the Aqueous Spray Manufacturers segment dominated the market and holds approximately 88% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
  • Both government actions and modern health care regulations are aiding the South Korean market for nasal spray, while antipollution nasal sprays have been forecasted to attain $196.1 million by 2033.

How is Technology Driving Growth in the South Korea Nasal Spray Market?

The South Korea Nasal Spray Market is experiencing growth due to technology with regards to advanced drug delivery methods, dosage accuracy, digitalization of healthcare and pharmaceutical developments. Microatomization and better engineering of sprays facilitate accurate dosing and higher nasal absorption, while new formulae could lead to improved efficacy of treatments. The integration of digital healthcare and platforms helps to increase engagement of patients and treatment monitoring, while biotechnological research facilitates the emergence of target-specific and peptide-based intranasal therapies. Automated production processes and quality control help to achieve greater scalability and reliability of production in South Korea's nasal spray market.

Market Drivers

The nasals spray market in South Korea is stimulated by the presence of large particulate matter in addition to pollution, which exacerbates the problem of allergic rhinitis and respiratory diseases, thus increasing the need for protection and cleansing nasal sprays. The elderly population with a higher rate of occurrence of sinus and nasal problems keeps the demand consistent. Good biotechnological expertise and strong research support promotes local innovation and product commercialization. In addition, the large proportion of smartphones makes it easy to develop companion applications that help track symptoms and adherence. All of this combined helps in maintaining the growth of the market over the forecast period.

Restrain

Strict rules in terms of product approval for both combination and digital products pose challenges to product launches; at the same time, price fluctuations associated with precision elements make the products expensive. Reimbursement and price regulations pose additional risks to margins of prescription products. The risk of adverse events such as nosebleeds and rebound congestion related to decongestant misuse can lower consumer trust in the products, along with problems with devices.

Driver

Relative Impact on Growth (%)

Geographic Relevance

Impact Timeline

Demand Strength

Growth Mechanism

Key Beneficiaries

Major Constraint

Rising Allergic Rhinitis and Respiratory Conditions

28%

Seoul, Incheon, Gyeonggi, major urban centers

Short-term

High

Increases demand for convenient allergy and respiratory treatments.

Nasal spray manufacturers, pharmacies, allergy-care providers, consumers

Seasonal demand variability and treatment alternatives

Air Pollution and Fine-Particulate Exposure

24%

Seoul Metropolitan Area, industrial urban centers

Short-term

High

Drives preventive, cleansing, hydrating, and anti-pollution nasal-care adoption.

Anti-pollution spray manufacturers, pharmacies, online retailers, consumers

Limited clinical differentiation among preventive products

Advanced Intranasal Drug-Delivery Technologies

20%

South Korea nationwide, technology-intensive healthcare centers

Medium-term

High

Improves dosing precision, absorption, convenience, and therapeutic performance.

Pharmaceutical companies, device manufacturers, technology vendors, patients

Development costs and regulatory validation requirements

Expansion of OTC and Self-Care Healthcare

16%

Nationwide, especially urban retail and e-commerce channels

Short-term

Medium

Expands consumer access to convenient nasal-care and symptom-relief products.

OTC manufacturers, pharmacies, e-commerce platforms, consumers

Consumer awareness and responsible self-medication requirements

Pharmaceutical R&D and Local Healthcare Innovation

12%

Seoul, Gyeonggi, major biotech and pharmaceutical clusters

Long-term

Medium

Supports formulation innovation, manufacturing capabilities, and specialized

Analysis of Prices and Consumer Behaviour

In South Korea, the market share of nasal sprays is dominated by highly purified and standardized products (68% of the total market; due to the demand from the allergy treatment, respiratory healthcare, and pharmaceutical industries). The cost of production of highly purified and standardized nasal spray containing advanced active ingredients will be estimated at 35% more than that of other products, since the development of such product is possible only via advanced formulation techniques, certified manufacturing processes, and high effectiveness. Almost 45% of all units sold of nasal sprays are sold in powder or dry form formulations. This trend is caused by the versatility of the product usage in respiratory healthcare and allergy treatments and high storability of dry nasal spray formulations. In total, the pharmaceutical and respiratory healthcare industries demand 70% of nasal sprays in South Korea. According to consumer behavior in the market, 55% of consumers give priority to the therapeutic effectiveness, purity, and standardized active ingredients in the product. Another 33% of consumers tend to buy the products via bulk or long-term agreements since they seek to reduce their procurement expenses and ensure reliable supplies of healthcare products in South Korea.

Company

Est. Revenue Share Range

Key Offerings

Strategic Positioning

Geographic Strength

Technology Focus

Haleon plc

8–12%

Otrivin; respiratory OTC products; allergy and congestion treatments

Strong OTC respiratory healthcare positioning

Asia Pacific; Europe; North America

Advanced OTC nasal delivery and dosing systems

Bayer AG

8–12%

Otrivin; decongestant nasal sprays; allergy and cold-care products

Broad consumer-health portfolio diversification

Europe; Asia Pacific; North America

Precision nasal formulations and metered-dose delivery

Sanofi SA

6–9%

Nasic; nasal decongestant products; allergy-care formulations

Established respiratory and allergy-care presence

Europe; Asia Pacific; North America

Formulation optimization and intranasal drug delivery

GSK plc

5–8%

Flonase-related allergy products; nasal corticosteroid solutions; respiratory healthcare

Specialized allergy and respiratory-care portfolio

North America; Europe; Asia Pacific

Corticosteroid formulations and nasal absorption technologies

Daewoong Pharmaceutical

4–7%

Prescription nasal formulations; respiratory medicines; local pharmaceutical products

Regional pharmaceutical innovation and localization

South Korea; Asia Pacific

Advanced pharmaceutical formulations and delivery technologies

Dong-A Pharmaceutical

3–6%

Nasal-care products; OTC healthcare products; respiratory-care formulations

Domestic OTC healthcare and pharmacy-channel strength

South Korea; Asia Pacific

Consumer healthcare formulation and delivery technologies

Yuyu Pharma

2–5%

Nasal decongestant products; allergy treatments; respiratory medicines

Domestic specialty and respiratory-care specialization

South Korea; Asia Pacific

Intranasal formulation and pharmaceutical manufacturing

Viatris Inc.

2–4%

Generic nasal sprays; corticosteroid formulations; allergy therapies

Generic portfolio breadth and cost efficiency

North America; Europe; Asia Pacific

Generic formulation development and scalable manufacturing

Cipla Limited

1–3%

Nasal corticosteroids; antihistamine sprays; respiratory therapies

Respiratory-focused portfolio and regional expansion

Asia Pacific; Middle East & Africa; North America

Respiratory drug delivery and formulation innovation

Novartis AG

1–3%

Allergy therapies; respiratory medicines; intranasal treatment portfolio

Specialty pharmaceutical and innovation-led positioning

Europe; North America; Asia Pacific

Specialty formulations and targeted drug delivery

Who are the Key Players in the South Korea Nasal Spray Market and how do they compete?

Competitiveness of the international market of South Korea Nasal Spray Market relies on the companies focused on the development of pharmaceutical innovations, nasal drug delivery technologies, and building of distribution channels across the world. Competing not on price but rather on innovative formulations, innovative technologies of nasal drug delivery, patient-oriented solutions and integration with the healthcare platform and pharmaceutical system, such a competitive strategy implies continuous innovation as well as increased effectiveness of treatment, patient convenience and healthcare efficiency.

With the development of innovative nasal spray formulations, nasal delivery technologies, and pharmaceutical technologies oriented towards patient, Haleon strengthens its position in the market. With the development of high quality pharmaceutical products designed to provide relief for allergies, respiratory care and nasal congestion, and other healthcare applications, Johnson & Johnson distinguishes itself from its competitors. Bayer positions itself with the help of integrated solutions in the field of nasal healthcare, pharmaceutical innovations, respiratory care, and consumer health.

Top Companies in the South Korea Nasal Spray Market

  1. Haleon
  2. Johnson & Johnson
  3. Bayer
  4. Sanofi
  5. GSK
  6. AstraZeneca
  7. Novartis
  8. Viatris
  9. Cipla
  10. Dr. Reddy's Laboratories
  11. Takeda
  12. Daewoong Pharmaceutical
  13. Hanmi Pharmaceutical
  14. Yuhan Corporation
  15. Chong Kun Dang

South Korea Nasal Spray Market Segmentation 

The South Korea Nasal Spray Market share is divided into five categories: By Product, By Indication, By Dosage Form, By Distribution, By End User

The Steroid dominated the market, accounting for nearly 41.2% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The South Korea Nasal Spray Market is segmented by product into decongestant sprays, steroid sprays, antihistamine sprays, saline sprays, combination sprays, anticholinergic sprays, other nasal sprays. Among these, the Steroid segment dominated the market, accounting for nearly 41.2% in 2025 and expected to increase at a significant CAGR during the forecast period. The lead position goes to steroid sprays since they offer clinically proven relief from allergic rhinitis and chronic nasal inflammation.

The Allergic Rhinitis dominated the market, accounting for nearly 55% in 2025, and is expected to rise at a significant CAGR during the forecast period.

The South Korea Nasal Spray Market is segmented by indication into allergic rhinitis, non-allergic rhinitis, nasal congestion, sinusitis, common cold, nasal polyps, other respiratory conditions. Among these, the Allergic Rhinitis dominated the market, accounting for nearly 55% in 2025 and expected to increase at a significant CAGR during the forecast period. Allergic rhinitis becomes the leader due to its high prevalence caused by fine dust, pollen, and pollution resulting in the need for nasal sprays.

The Aqueous Spray dominated the market, accounting for nearly 88% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The South Korea Nasal Spray Market is segmentedby dosage form into aqueous spray, powder spray, gel spray, metered-dose spray, pump spray, preservative-free spray, combination formulation. Among these, the Aqueous Spray dominated the market, accounting for nearly 88% in 2025 and expected to increase at a significant CAGR during the forecast period. Aqueous sprays become the leaders due to ease of administration and good tolerability allowing them to be used both for prescription and OTC treatments.

South Korea Nasal Spray Market Indication

Future Market Trends for the South Korea Nasal Spray Market:-

  1. Gentle and natural formulations: With increasing consumer interest in gentle non-medical treatments, there is an increase in the popularity of natural, preservative-free and physiological saline nasal sprays in South Korea due to increasing respiratory health consciousness.
  2. Device technology advances and digital health: Companies are improving atomization, dose accuracy and spray pattern, pH balanced formulas that are less irritating, and also app-connected devices are in development stage.
  3. Improved accessibility and supply chain: Through increased availability of digital health and online channels, the accessibility of nasal sprays is improving, and also increased local production will help in stabilizing the supply chain.

Recent Development

  • In May 2026: Growth rate for the corticosteroid nasal spray segment in South Korea was seen at a projected annual volume increase of 4–6% based on the growing awareness of air pollution and allergens.
  • In September 2026: The multi-dose nasal spray and antihistamine segments in South Korea launched initiatives focused on advanced technology, patient compliance, and digital healthcare integration.

Market Segmentation

This study forecasts revenue at Japan, regional and country levels from 2020 to 2033. Transpire Insight has segmented the South Korea Nasal Spray Market based on the below-mentioned segments:

South Korea Nasal Spray Market, By Product

  • Decongestant Sprays
  • Steroid Sprays
  • Antihistamine Sprays
  • Saline Sprays
  • Combination Sprays
  • Anticholinergic Sprays
  • Other Nasal Sprays

South Korea Nasal Spray Market, By Indication

  • Allergic Rhinitis
  • Non-Allergic Rhinitis
  • Nasal Congestion
  • Sinusitis
  • Common Cold
  • Nasal Polyps
  • Other Respiratory Conditions

South Korea Nasal Spray Market, By Dosage Form

  • Aqueous Spray
  • Powder Spray
  • Gel Spray
  • Metered-Dose Spray
  • Pump Spray
  • Preservative-Free Spray
  • Combination Formulation

South Korea Nasal Spray Market, By Distribution

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drugstores
  • Supermarkets
  • Clinics
  • Direct Sales

South Korea Nasal Spray Market, By End User

  • Adults
  • Pediatrics
  • Elderly
  • Allergy Patients
  • Cold & Flu Patients
  • Chronic Rhinitis Patients
  • Postoperative Patients

Frequently Asked Questions

Find quick answers to common questions.

  1. Haleon
  2. Johnson & Johnson
  3. Bayer
  4. Sanofi
  5. GSK
  6. AstraZeneca
  7. Novartis
  8. Viatris
  9. Cipla
  10. Dr. Reddy's Laboratories
  11. Takeda
  12. Daewoong Pharmaceutical
  13. Hanmi Pharmaceutical
  14. Yuhan Corporation
  15. Chong Kun Dang

About the Authors

Pankaj Ghogare Patil -Author TI

Pankaj Ghogare Patil

I am Pankaj Ghogare Patil, a Senior Research Analyst at Transpire Insight, specializing in the Pharmaceutical, Chemicals & Materials, Healthcare IT, and Biotechnology industry. My expertise lies in conducting comprehensive market research, analyzing industry trends, evaluating competitive landscapes, and translating complex data into actionable insights. At Transpire Insight, I closely follow emerging technologies, regulatory developments, and market innovations to create accurate, well-researched, and informative content that helps businesses and professionals make informed decisions. I am committed to producing credible, evidence-based articles that reflect industry best practices while making technical topics accessible and valuable for a broad audience.

Chakradhar Khansole -Author TI

Chakradhar Khansole

Chakradhar serves as the Research Director at Transpire Insight, bringing over 8 years of experience in technology, innovation, and strategic market intelligence. He specializes in transforming complex market data into actionable business insights that enable organizations to make informed, growth-oriented decisions. Recognized for his strategic vision and analytical expertise, Chakradhar leads high-impact research initiatives, delivering comprehensive market assessments, competitive intelligence, and forward-looking industry analysis.

Recently Published Reports

Our Clients

client-logo_(1).jpg
client-logo.jpg
client-logo1.jpg
client-logo2.jpg
client-logo3.jpg
client-logo7.jpg
client-logo11.jpg
client-logo31.jpg